Day: April 4, 2020

COPPER LAKE ANNOUNCES RELIANCE ON INTERIM FINANCIAL STATEMENT FILING EXEMPTION

TORONTO, April 04, 2020 (GLOBE NEWSWIRE) — Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: W0I) (“Copper Lake” or the “Company”) announces that pursuant to the blanket relief granted by the Canadian Securities Administrators it did not file its interim financial statements for the quarter ended January 31, 2020, and the related management’s discussion and analysis, as required by Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Obligations (collectively, the “Interim Filings”) by the filing deadline of March 30, 2020.  The Company expects to report results on or about April 17, 2020, and is afforded a postponement up to a maximum 45-day extension pursuant to blanket relief for all market participants granted by the Canadian Securities Administrators.Other than as disclosed in the Company’s...

Continue reading

Saudi Arabias Ambition Towards a Cashless Kingdom by 2030

April 2020 – ​As a part of its Vision 2030, the Kingdom of Saudi Arabia has set an ambitious target in the financial sector development to achieve 70% of non-cash transactions by 2030. Opportunities arise for fintech players looking to enter a new market with high consumer demands, as the Kingdom pushes with government-backed initiatives and incubators, according to our latest white paper titled ​“​Saudi Arabia’s Road Towards Becoming a Cashless Society by 2030​”. Three Key Pillars Towards Saudi’s Cashless Society1.Digitally-Enabled and Financially Literate PopulationThe Saudi population that understands how to utilize digital payment solutions will be the prominent driver towards a cashless economy. Around 70% of the Kingdom’s population is under the age of 30 with high smartphone penetration at 93.3%. The demand for contactless...

Continue reading

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

Bagsværd, Denmark, 4 April 2020 – Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus® (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabetes to improve glycaemic control as an adjunct to diet and exercise. The marketing authorisation applies to all 27 European Union member states and the United Kingdom.Rybelsus® is the first and only oral glucagon-like-peptide-1 (GLP-1) receptor agonist. The approval is based on the results from 10 PIONEER clinical trials, in which Rybelsus® after 52 weeks demonstrated statistically significant reductions in HbA1c vs sitagliptin, empagliflozin and liraglutide and with up to 4.3 kg weight reduction. Across the PIONEER programme, Rybelsus® demonstrated a safe and well-tolerated profile, with the most...

Continue reading

Brookfield Infrastructure to Issue $400 Million of Medium Term Notes

All amounts in Canadian dollarsNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATESBROOKFIELD, NEWS, April 03, 2020 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announced that it has agreed to sell $400 million aggregate principal amount of medium term notes (the “Additional Notes”), comprised of $200 million aggregate principal amount of a re-opening of its 4.193% medium term notes, Series 6 (the “Additional Series 6 Notes”), due September 11, 2028 and $200 million aggregate principal amount of a re-opening of its 3.41% medium term notes, Series 7 (the “Additional Series 7 Notes”), due October 9, 2029. A subsidiary of Brookfield Infrastructure, Brookfield Infrastructure Finance ULC will be the recipient of the net proceeds and have primary responsibility for the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.